Skip to main content

Published locations for Imatinib Mesylate Said to Offer Promise for Scleroderma Patients : Tyrosine kinase inhibitor appears to reduce skin thickness and improve lung function.

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Imatinib Mesylate Said to Offer Promise for Scleroderma Patients : Tyrosine kinase inhibitor appears to reduce skin thickness and improve lung function.

User login

  • Reset your password
  • /content/imatinib-mesylate-said-offer-promise-scleroderma-patients-tyrosine-kinase-inhibitor-appears
  • /rheumatologynews/article/45633/lupus-connective-tissue-diseases/imatinib-mesylate-said-offer-promise
  • /rheumatology/article/45633/lupus-connective-tissue-diseases/imatinib-mesylate-said-offer-promise